Detecting Early-Stage Cancers with a New Blood Test Measuring Epigenetic Instability

Investigadoras en el Centro Oncológico Johns Hopkins Kimmel have developed a novel liquid biopsy approach to identify early-stage cancers by measuring the random variation in DNA methylation patterns, rather than the absolute level of those patterns as in other liquid biopsies.

APRENDE MÁS

VER TODAS LAS NOTICIAS

Mensajes recientes

Colon Cancer Screening: What You Need to Know Oral Bacterium May Promote Breast Cancer Development and Spread Extra Copies of Chromosome 1q May Drive Pancreatic Cancer How Bacteria May Promote Breast Cancer Growth of Spreading Pancreatic Cancer Fueled By “Under-Appreciated” Epigenetic Changes Updated Guidelines Standardize How Tumor Response Is Measured After Surgery Running the Distance: Patient Teams with Johns Hopkins Medicine Dermatologists to Treat, Understand Rare Hereditary Cancer Syndrome New Technology: MRI-guided Focused Ultrasound for Prostate Cancer Advances in Breast Cancer Treatment: Insights from Medical Oncologist Jenni Sheng